• [email protected]
  • +971 507 888 742
Submit Manuscript
SciAlert
  • Home
  • Journals
  • Information
    • For Authors
    • For Referees
    • For Librarian
    • For Societies
  • Contact
  1. American Journal of Biochemistry and Molecular Biology
  2. Vol 13 (1), 2023
  3. 5-10
  • Online First
  • Current Issue
  • Previous Issues
  • More Information
    Aims and Scope Editorial Board Guide to Authors Article Processing Charges
    Submit a Manuscript

American Journal of Biochemistry and Molecular Biology

Year: 2023 | Volume: 13 | Issue: 1 | Page No.: 5-10
DOI: 10.3923/ajbmb.2023.5.10

Facebook Twitter Digg Reddit Linkedin StumbleUpon E-mail

Article Trend



Total views 1212

Search


Authors


Babacar  Faye

Babacar Faye

LiveDNA: 221.38653

Fahimat Ahamada

Country: Senegal

Jean A.D. Tine

Country: Senegal

Doudou G.M. Niang

Country: Senegal

Babacar Mbengue

Country: Senegal

Alioune Dieye

Country: Senegal

Keywords


  • respiratory distress
  • SARS-CoV-2
  • Abbott RealTime
  • Cepheid Xpert Xpress
  • comparison
  • RT-PCR
  • cap structure
Research Article

Comparison of Abbott Real Time SARS-CoV-2 and Cepheid Xpert Xpress SARS-CoV-2 in Molecular Diagnosis of COVID-19

Babacar Faye Babacar  Faye's LiveDNA, Fahimat Ahamada, Jean A.D. Tine, Doudou G.M. Niang, Babacar Mbengue and Alioune Dieye
Background and Objective: In December 2019 in Wuhan (China), SARS-CoV-2 was identified as the agent responsible for the COVID-19 epidemic. The expansion of this disease encourages greater epidemiological surveillance and molecular techniques capable of making the diagnosis regardless of its variant. The objective of the current study was to compare the concordance between two molecular diagnostic techniques, Abbott RealTime m2000 SARS-CoV-2 and Cepheid Xpert Xpress SARS-CoV-2 in the diagnosis of COVID-19. Materials and Methods: A total of 92 oral and nasopharyngeal samples were tested by PCR on Abbott RealTime SARS-CoV-2 and o Cepheid Xpert Xpress SARS-CoV-2. The data were subjected to statistical analysis to evaluate their degree of concordance. Results: The two tests had an overall agreement of 94.57% (95% CI: 87.9-97.66), a positive agreement of 100%, a negative agreement of 90% with a Kappa coefficient κ = 89.15% (95% CI: 68.84-100). About 5 samples tested negative on Abbott were positive on Cepheid with high Ct values (Ct: Cycle threshold) greater than 40. The correlation coefficient was r = 0.82, (p = 2.2×10–16) and showed good similarity in performance. Conclusion: The two techniques are comparable in terms of performance because the results showed excellent agreement. The Cepheid technique with more amplification cycles has a better detection threshold.
PDF Fulltext XML References Citation

How to cite this article

Babacar Faye, Fahimat Ahamada, Jean A.D. Tine, Doudou G.M. Niang, Babacar Mbengue and Alioune Dieye, 2023. Comparison of Abbott Real Time SARS-CoV-2 and Cepheid Xpert Xpress SARS-CoV-2 in Molecular Diagnosis of COVID-19. American Journal of Biochemistry and Molecular Biology, 13: 5-10.

DOI: 10.3923/ajbmb.2023.5.10

URL: https://scialert.net/abstract/?doi=ajbmb.2023.5.10

Leave a Comment


Your email address will not be published. Required fields are marked *

Useful Links

  • Journals
  • For Authors
  • For Referees
  • For Librarian
  • For Socities

Contact Us

Office Number 1128,
Tamani Arts Building,
Business Bay,
Deira, Dubai, UAE

Phone: +971 507 888 742
Email: [email protected]

About Science Alert

Science Alert is a technology platform and service provider for scholarly publishers, helping them to publish and distribute their content online. We provide a range of services, including hosting, design, and digital marketing, as well as analytics and other tools to help publishers understand their audience and optimize their content. Science Alert works with a wide variety of publishers, including academic societies, universities, and commercial publishers.

Follow Us
© Copyright Science Alert. All Rights Reserved